4//SEC Filing
Brumm Joshua T 4
Accession 0000950170-24-024300
CIK 0001818794other
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 9:38 PM ET
Size
19.4 KB
Accession
0000950170-24-024300
Insider Transaction Report
Form 4
Brumm Joshua T
DirectorSee Remarks
Transactions
- Sale
Common Stock
2024-03-01$29.23/sh−74,090$2,165,651→ 564,885 total - Exercise/Conversion
Stock option (right to buy)
2024-02-29−5,520→ 102,343 totalExercise: $5.54Exp: 2030-07-30→ Common Stock (5,520 underlying) - Exercise/Conversion
Stock option (right to buy)
2024-03-01−57,843→ 44,500 totalExercise: $5.54Exp: 2030-07-30→ Common Stock (57,843 underlying) - Exercise/Conversion
Stock option (right to buy)
2024-03-01−36,637→ 342,681 totalExercise: $5.54Exp: 2030-07-30→ Common Stock (36,637 underlying) - Exercise/Conversion
Common Stock
2024-02-29$5.54/sh+5,520$30,581→ 568,991 total - Sale
Common Stock
2024-02-29$27.50/sh−5,520$151,800→ 563,471 total - Sale
Common Stock
2024-03-01$28.25/sh−18,976$536,072→ 638,975 total - Sale
Common Stock
2024-03-01$29.70/sh−1,414$41,996→ 563,471 total - Exercise/Conversion
Common Stock
2024-03-01$5.54/sh+94,480$523,419→ 657,951 total
Footnotes (7)
- [F1]Includes 530,300 unvested RSUs.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $27.50 to $27.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes of this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $27.50 to $28.48, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $28.56 to $29.56, inclusive.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $29.58 to $29.88, inclusive.
- [F7]The option was granted on July 31, 2020. The shares underlying the option vest over four years in equal quarterly installments through July 31, 2024.
Documents
Issuer
Dyne Therapeutics, Inc.
CIK 0001818794
Entity typeother
Related Parties
1- filerCIK 0001528826
Filing Metadata
- Form type
- 4
- Filed
- Feb 29, 7:00 PM ET
- Accepted
- Mar 1, 9:38 PM ET
- Size
- 19.4 KB